New Zealand markets close in 5 hours 47 minutes

GlaxoSmithKline plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
22.90+0.42 (+1.89%)
At close: 03:52PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 107.26B
Enterprise value 136.47B
Trailing P/E 18.92
Forward P/E 13.89
PEG ratio (5-yr expected) 3.61
Price/sales (ttm)2.45
Price/book (mrq)5.25
Enterprise value/revenue 4.09
Enterprise value/EBITDA 12.36

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 319.96%
S&P500 52-week change 322.74%
52-week high 322.90
52-week low 316.50
50-day moving average 321.06
200-day moving average 319.83

Share statistics

Avg vol (3-month) 318.41k
Avg vol (10-day) 32.54k
Shares outstanding 55.03B
Implied shares outstanding 6N/A
Float 84.9B
% held by insiders 11.24%
% held by institutions 151.30%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.1
Forward annual dividend yield 44.79%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 33.56%
5-year average dividend yield 45.30
Payout ratio 493.96%
Dividend date 313 Apr 2016
Ex-dividend date 417 Nov 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 12.94%
Operating margin (ttm)24.78%

Management effectiveness

Return on assets (ttm)6.47%
Return on equity (ttm)23.62%

Income statement

Revenue (ttm)33.33B
Revenue per share (ttm)6.67
Quarterly revenue growth (yoy)5.00%
Gross profit (ttm)23.21B
EBITDA 10.23B
Net income avi to common (ttm)4.31B
Diluted EPS (ttm)1.17
Quarterly earnings growth (yoy)-6.10%

Balance sheet

Total cash (mrq)3.51B
Total cash per share (mrq)0.7
Total debt (mrq)25.6B
Total debt/equity (mrq)117.74
Current ratio (mrq)0.81
Book value per share (mrq)3.08

Cash flow statement

Operating cash flow (ttm)8.04B
Levered free cash flow (ttm)8.77B